Story preview
Continue reading on the publisher site for the full article.
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
13
in the last 3 days
First reported
38 hr. ago
12 outlets since
Countries
12 other outlets reported this story in the last 3 days.
Eli Lilly trades at a premium multiple, yet its revenue growth dwarfs every major pharma peer by a wide margin. Whether that gap justifies buying shares near all-time highs depends on one critical assumption about Lilly's pipeline.
On October 13, 2026, Eli Lilly and Co (LLY) shares fell 1.4%, closing at $1166.51. The stock has fluctuated within a 52-week range of $783.85 to $1292.65, refle
Eli Lilly's stock price is comfortably above $1,000, and management could easily justify doing a stock split.